The abstract is read at the publisher; the summary is JClub's.
Loss of Mosmo in NIH/3T3 mouse fibroblasts confers resistance to Smoothened (SMO) Hedgehog pathway inhibitors, revealing a class-specific genetic modifier tied to ciliary signaling.
- Why it matters: Non-toxic Hedgehog inhibitors need mechanism and resistance insights, but compound–gene interactions are not well resolved across inhibitor classes.
- What they did: Hedgehog pathway-focused genetic screens were run in NIH/3T3 fibroblasts using two chemically distinct SMO inhibitors and two BET bromodomain inhibitors, then chemogenetic profiles were compared.
- The result: Loss of Paxip1 confers resistance to BET bromodomain inhibitors, and Nf2, Paxip1, or Mosmo knockouts differentially affect Hedgehog transduction at the cilium and/or transcription, enabling epistasis mapping and mechanism-of-action studies.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.